Cleveland Clinic recorded operating income of $326.6 million (6.5% operating margin) during the third quarter of 2026, up from operating income of $206.2 million (4.5% margin) during the same period last year, according to its Nov. 16 financial report.
Five things to know:
1. Cleveland Clinic attributed the higher operating margin to a 10.7% year-over-year increase in operating revenue for the three months ended Sept. 30, which outpaced an 8.5% increase in operating expenses.
2. The system reported total operating revenue of $5 billion in the third quarter of 2026, up from $4.5 billion during the same period last year. Net patient service revenue totaled $4.1 billion, up from $3.7 billion. Total patient encounters increased 4.1%, driven by a 1.2% increase in acute admissions, a 1.3% increase in total surgical cases and a 7.1% increase in outpatient evaluation and management visits. Net patient service revenue also increased due to annual rate increases on managed care contracts that took effect in 2026.
3. Total operating expenses were $4.5 billion, up from $4.1 billion. Cleveland Clinic said the growth in expenses was primarily due to growth in patient volumes and inflationary trends that increased personnel, supplies and pharmaceutical expenses. Salaries, wages and benefits totaled $2.5 billion, up from $2.3 billion. Pharmaceutical expenses totaled $818.8 million, up from $701 million. Supply expenses totaled $452.8 million, up from $427.1 million. Insurance expense totaled $21 million, down from $80.7 million, primarily due to a favorable adjustment to professional liability insurance expense based on an updated actuarial analysis.
4. The system reported net income of $478.9 million in the third quarter of 2026, down from $706.2 million during the same period last year. Nonoperating gains totaled $152.3 million, down from $500 million, primarily due to less favorable investment returns.
5. For the nine months ended Sept. 30, Cleveland Clinic reported operating income of $745 million (5.1% operating margin), up from $514.4 million (3.9% margin) during the same period last year.